BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 22876893)

  • 1. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V; Ververs TF; Visser GH; Gazzolo D
    Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
    Gentile S
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective serotonin reuptake inhibitors and pregnancy].
    Hassanzadeh T; Pedersen LH; Videbech P
    Ugeskr Laeger; 2014 Feb; 176(3):236-9. PubMed ID: 24629751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
    Cantor Sackett J; Weller RA; Weller EB
    Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antidepressant use in pregnancy: a critical review of the risk and benefits].
    Goracci A; Valdagno M; Maltinti E; Sillari S; Fagiolini A
    Riv Psichiatr; 2015; 50(3):118-26. PubMed ID: 26156817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of selective serotonin reuptake inhibitors in pregnancy.
    Alwan S; Friedman JM
    CNS Drugs; 2009; 23(6):493-509. PubMed ID: 19480468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of antidepressants during pregnancy].
    Pedersen LH; Videbech P
    Ugeskr Laeger; 2011 Apr; 173(15):1118-20. PubMed ID: 21672461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors and malformations: case closed?
    Koren G; Nordeng HM
    Semin Fetal Neonatal Med; 2013 Feb; 18(1):19-22. PubMed ID: 23228547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SSRIs and pregnancy: a review of the literature].
    Soufia M; Aoun J; Gorsane MA; Krebs MO
    Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.
    Ornoy A; Koren G
    Semin Fetal Neonatal Med; 2014 Jun; 19(3):188-94. PubMed ID: 24321501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal SSRI exposure: Effects on later child development.
    Hermansen TK; Melinder A
    Child Neuropsychol; 2015; 21(5):543-69. PubMed ID: 25089614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC; Saccone G; Berghella V
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
    Olivier JD; Åkerud H; Sundström Poromaa I
    Eur J Pharmacol; 2015 Apr; 753():257-62. PubMed ID: 25094036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
    J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.